BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

364 related articles for article (PubMed ID: 36514127)

  • 1. Associations of MRI-visible perivascular spaces with longitudinal cognitive decline across the Alzheimer's disease spectrum.
    Wang ML; Zou QQ; Sun Z; Wei XE; Li PY; Wu X; Li YH;
    Alzheimers Res Ther; 2022 Dec; 14(1):185. PubMed ID: 36514127
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Perivascular Space Predicts Brain Hypometabolism of Individuals with Underlying Amyloid Pathology.
    Shi X; Zhou N; Sun B; Wu Y; Hu Y; Ning Y;
    J Alzheimers Dis; 2022; 90(3):1329-1337. PubMed ID: 36245373
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MRI Visible Perivascular Spaces and the Risk of Incident Mild Cognitive Impairment in a Community Sample.
    Pase MP; Pinheiro A; Rowsthorn E; Demissie S; Hurmez S; Aparicio HJ; Rodriguez-Lara F; Gonzales MM; Beiser A; DeCarli C; Seshadri S; Romero JR
    J Alzheimers Dis; 2023; 96(1):103-112. PubMed ID: 37742645
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of Enlarged Perivascular Spaces With Amyloid Burden and Cognitive Decline in Alzheimer Disease Continuum.
    Jeong SH; Cha J; Park M; Jung JH; Ye BS; Sohn YH; Chung SJ; Lee PH
    Neurology; 2022 Oct; 99(16):e1791-e1802. PubMed ID: 35985826
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MRI-Visible Perivascular Spaces Associated With Cognitive Impairment in Military Veterans With Traumatic Brain Injury Mediated by CSF P-Tau.
    Wang ML; Yang DX; Sun Z; Li WB; Zou QQ; Li PY; Wu X; Li YH
    Front Psychiatry; 2022; 13():921203. PubMed ID: 35873253
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bayesian estimation for the accuracy of three neuropsychological tests in detecting Alzheimer's disease and mild cognitive impairment: a retrospective analysis of the ADNI database.
    Wang X; Li F; Tian J; Gao Q; Zhu H
    Eur J Med Res; 2023 Oct; 28(1):427. PubMed ID: 37821912
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alzheimer's Disease Assessment Scale-Cognitive subscale variants in mild cognitive impairment and mild Alzheimer's disease: change over time and the effect of enrichment strategies.
    Podhorna J; Krahnke T; Shear M; Harrison JE;
    Alzheimers Res Ther; 2016 Feb; 8():8. PubMed ID: 26868820
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predicting conversion of patients with Mild Cognitive Impairment to Alzheimer's disease using bedside cognitive assessments.
    Clarke A; Ashe C; Jenkinson J; Rowe O; A D N I ; Hyland P; Commins S
    J Clin Exp Neuropsychol; 2022 Dec; 44(10):703-712. PubMed ID: 36803664
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MRI-Visible Perivascular Spaces and Risk of Incident Dementia: The Framingham Heart Study.
    Romero JR; Pinheiro A; Aparicio HJ; DeCarli CS; Demissie S; Seshadri S
    Neurology; 2022 Dec; 99(23):e2561-e2571. PubMed ID: 36175148
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cognitive reserve and clinical progression in Alzheimer disease: A paradoxical relationship.
    van Loenhoud AC; van der Flier WM; Wink AM; Dicks E; Groot C; Twisk J; Barkhof F; Scheltens P; Ossenkoppele R;
    Neurology; 2019 Jul; 93(4):e334-e346. PubMed ID: 31266904
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Longitudinal Exposure-Response Modeling of Multiple Indicators of Alzheimer's Disease Progression.
    Polhamus DG; Dolton MJ; Rogers JA; Honigberg L; Jin JY; Quartino A
    J Prev Alzheimers Dis; 2023; 10(2):212-222. PubMed ID: 36946448
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Validation study of the Alzheimer's disease assessment scale-cognitive subscale (ADAS-Cog) for the Portuguese patients with mild cognitive impairment and Alzheimer's disease.
    Nogueira J; Freitas S; Duro D; Almeida J; Santana I
    Clin Neuropsychol; 2018; 32(sup1):46-59. PubMed ID: 29566598
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Associations Between Vascular Risk Factors and Perivascular Spaces in Adults with Intact Cognition, Mild Cognitive Impairment, and Dementia.
    Rundek T; Del Brutto VJ; Goryawala M; Dong C; Agudelo C; Saporta AS; Merritt S; Camargo C; Ariko T; Loewenstein DA; Duara R; Haq I
    J Alzheimers Dis; 2022; 89(2):437-448. PubMed ID: 35871327
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disease trajectories in elders with suspected non-Alzheimer's pathophysiology and its comparison with Alzheimer's disease pathophysiology: a longitudinal study.
    Li JQ; Song JH; Suckling J; Wang YJ; Zuo CT; Zhang C; Gao J; Song YQ; Xie AM; Tan L; Yu JT
    Res Sq; 2023 Mar; ():. PubMed ID: 37034751
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Associations of White Matter Hyperintensities with Cognitive Decline: A Longitudinal Study.
    Wang YL; Chen W; Cai WJ; Hu H; Xu W; Wang ZT; Cao XP; Tan L; Yu JT;
    J Alzheimers Dis; 2020; 73(2):759-768. PubMed ID: 31839612
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development and assessment of a composite score for memory in the Alzheimer's Disease Neuroimaging Initiative (ADNI).
    Crane PK; Carle A; Gibbons LE; Insel P; Mackin RS; Gross A; Jones RN; Mukherjee S; Curtis SM; Harvey D; Weiner M; Mungas D;
    Brain Imaging Behav; 2012 Dec; 6(4):502-16. PubMed ID: 22782295
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Machine Learning-Based Perivascular Space Volumetry in Alzheimer Disease.
    Deike K; Decker A; Scheyhing P; Harten J; Zimmermann N; Paech D; Peters O; Freiesleben SD; Schneider LS; Preis L; Priller J; Spruth E; Altenstein S; Lohse A; Fliessbach K; Kimmich O; Wiltfang J; Bartels C; Hansen N; Jessen F; Rostamzadeh A; Düzel E; Glanz W; Incesoy EI; Butryn M; Buerger K; Janowitz D; Ewers M; Perneczky R; Rauchmann BS; Teipel S; Kilimann I; Goerss D; Laske C; Munk MH; Spottke A; Roy N; Wagner M; Roeske S; Heneka MT; Brosseron F; Ramirez A; Dobisch L; Wolfsgruber S; Kleineidam L; Yakupov R; Stark M; Schmid MC; Berger M; Hetzer S; Dechent P; Scheffler K; Petzold GC; Schneider A; Effland A; Radbruch A
    Invest Radiol; 2024 Apr; ():. PubMed ID: 38652067
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Topography and Determinants of Magnetic Resonance Imaging (MRI)-Visible Perivascular Spaces in a Large Memory Clinic Cohort.
    Shams S; Martola J; Charidimou A; Larvie M; Granberg T; Shams M; Kristoffersen-Wiberg M; Wahlund LO
    J Am Heart Assoc; 2017 Sep; 6(9):. PubMed ID: 28939709
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glymphatic system impairment in Alzheimer's disease: associations with perivascular space volume and cognitive function.
    Zhang X; Wang Y; Jiao B; Wang Z; Shi J; Zhang Y; Bai X; Li Z; Li S; Bai R; Sui B
    Eur Radiol; 2024 Feb; 34(2):1314-1323. PubMed ID: 37610441
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cerebrospinal fluid synaptosomal-associated protein 25 is a key player in synaptic degeneration in mild cognitive impairment and Alzheimer's disease.
    Zhang H; Therriault J; Kang MS; Ng KP; Pascoal TA; Rosa-Neto P; Gauthier S;
    Alzheimers Res Ther; 2018 Aug; 10(1):80. PubMed ID: 30115118
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.